Funder
National Institute of Allergy and Infectious Diseases
University of North Carolina
Vaccine Research Center
Caisse des dépôts et consignations
National Cancer Institute
Subject
Cancer Research,Infectious Diseases,Virology
Reference64 articles.
1. Critical ACE2 determinants of SARS-CoV-2 and group 2B coronavirus infection and replication;Adams;mBio,2021
2. The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants;Ao;MedComm,2023
3. Comparison of COVID-19 severity in vaccinated and unvaccinated patients during the delta and Omicron wave of the pandemic in a romanian tertiary infectious diseases hospital;Briciu;Healthcare,2023
4. SARS-CoV-2 variant biology: immune escape, transmission and fitness;Carabelli;Nat. Rev. Microbiol.,2023
5. The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties - an alarming global threat of a surge in COVID-19 cases again?;Chakraborty;Int. J. Surg.,2023